Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2000 Nov-Dec;6(6):601–608. doi: 10.3201/eid0606.000608

Hemophagocytic syndromes and infection.

D N Fisman 1
PMCID: PMC2640913  PMID: 11076718

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is an unusual syndrome characterized by fever, splenomegaly, jaundice, and the pathologic finding of hemophagocytosis (phagocytosis by macrophages of erythrocytes, leukocytes, platelets, and their precursors) in bone marrow and other tissues. HLH may be diagnosed in association with malignant, genetic, or autoimmune diseases but is also prominently linked with Epstein-Barr (EBV) virus infection. Hyperproduction of cytokines, including interferon-gamma and tumor necrosis factor-alpha, by EBV- infected T lymphocytes may play a role in the pathogenesis of HLH. EBV-associated HLH may mimic T-cell lymphoma and is treated with cytotoxic chemotherapy, while hemophagocytic syndromes associated with nonviral pathogens often respond to treatment of the underlying infection.

Full Text

The Full Text of this article is available as a PDF (59.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aricò M., Janka G., Fischer A., Henter J. I., Blanche S., Elinder G., Martinetti M., Rusca M. P. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996 Feb;10(2):197–203. [PubMed] [Google Scholar]
  2. BOAKE W. C., CARD W. H., KIMMEY J. F. HISTIOCYTIC MEDULLARY RETICULOSIS; CONCURRENCE IN FATHER AND SON. Arch Intern Med. 1965 Aug;116:245–252. doi: 10.1001/archinte.1965.03870020085016. [DOI] [PubMed] [Google Scholar]
  3. Blanche S., Caniglia M., Girault D., Landman J., Griscelli C., Fischer A. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-center study of 22 cases. Blood. 1991 Jul 1;78(1):51–54. [PubMed] [Google Scholar]
  4. Burgio G. R., Aricò M., Marconi M., Lanfranchi A., Caselli D., Ugazio A. G. Spontaneous NBT reduction by monocytes as a marker of disease activity in children with histiocytosis. Br J Haematol. 1990 Feb;74(2):146–150. doi: 10.1111/j.1365-2141.1990.tb02557.x. [DOI] [PubMed] [Google Scholar]
  5. Chang C. S., Wang C. H., Su I. J., Chen Y. C., Shen M. C. Hematophagic histiocytosis: a clinicopathologic analysis of 23 cases with special reference to the association with peripheral T-cell lymphoma. J Formos Med Assoc. 1994 May;93(5):421–428. [PubMed] [Google Scholar]
  6. Chen J. S., Lin K. H., Lin D. T., Chen R. L., Jou S. T., Su I. J. Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens. Br J Haematol. 1998 Dec;103(3):756–762. doi: 10.1046/j.1365-2141.1998.01026.x. [DOI] [PubMed] [Google Scholar]
  7. Chen J. S., Tzeng C. C., Tsao C. J., Su W. C., Chen T. Y., Jung Y. C., Su I. J. Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome. Haematologica. 1997 Sep-Oct;82(5):572–576. [PubMed] [Google Scholar]
  8. Chen R. L., Lin K. H., Lin D. T., Su I. J., Huang L. M., Lee P. I., Hseih K. H., Lin K. S., Lee C. Y. Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol. 1995 Feb;89(2):282–290. doi: 10.1111/j.1365-2141.1995.tb03302.x. [DOI] [PubMed] [Google Scholar]
  9. Chen R. L., Su I. J., Lin K. H., Lee S. H., Lin D. T., Chuu W. M., Lin K. S., Huang L. M., Lee C. Y. Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullary reticulosis. An atypical form of Epstein-Barr virus infection. Am J Clin Pathol. 1991 Aug;96(2):171–176. doi: 10.1093/ajcp/96.2.171. [DOI] [PubMed] [Google Scholar]
  10. Craig F. E., Clare C. N., Sklar J. L., Banks P. M. T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am J Clin Pathol. 1992 Feb;97(2):189–194. doi: 10.1093/ajcp/97.2.189. [DOI] [PubMed] [Google Scholar]
  11. Dufourcq-Lagelouse R., Jabado N., Le Deist F., Stéphan J. L., Souillet G., Bruin M., Vilmer E., Schneider M., Janka G., Fischer A. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am J Hum Genet. 1999 Jan;64(1):172–179. doi: 10.1086/302194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dufourcq-Lagelouse R., Pastural E., Barrat F. J., Feldmann J., Le Deist F., Fischer A., De Saint Basile G. Genetic basis of hemophagocytic lymphohistiocytosis syndrome (Review). Int J Mol Med. 1999 Aug;4(2):127–133. doi: 10.3892/ijmm.4.2.127. [DOI] [PubMed] [Google Scholar]
  13. Esumi N., Ikushima S., Hibi S., Todo S., Imashuku S. High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer. 1988 May 15;61(10):2071–2076. doi: 10.1002/1097-0142(19880515)61:10<2071::aid-cncr2820611023>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  14. FARQUHAR J. W., CLAIREAUX A. E. Familial haemophagocytic reticulosis. Arch Dis Child. 1952 Dec;27(136):519–525. doi: 10.1136/adc.27.136.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Favara B. E. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol. 1992 Feb;9(1):63–74. [PubMed] [Google Scholar]
  16. Fujiwara F., Hibi S., Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol. 1993 Feb;15(1):92–98. doi: 10.1097/00043426-199302000-00012. [DOI] [PubMed] [Google Scholar]
  17. Gill D. S., Spencer A., Cobcroft R. G. High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome. Br J Haematol. 1994 Sep;88(1):204–206. doi: 10.1111/j.1365-2141.1994.tb05000.x. [DOI] [PubMed] [Google Scholar]
  18. Haddad E., Sulis M. L., Jabado N., Blanche S., Fischer A., Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997 Feb 1;89(3):794–800. [PubMed] [Google Scholar]
  19. Hasegawa D., Kojima S., Tatsumi E., Hayakawa A., Kosaka Y., Nakamura H., Sako M., Osugi Y., Nagata S., Sano K. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood. 1998 Apr 15;91(8):2793–2799. [PubMed] [Google Scholar]
  20. Henter J. I., Aricò M., Elinder G., Imashuku S., Janka G. Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998 Apr;12(2):417–433. doi: 10.1016/s0889-8588(05)70520-7. [DOI] [PubMed] [Google Scholar]
  21. Henter J. I., Ehrnst A., Andersson J., Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr. 1993 Apr;82(4):369–372. doi: 10.1111/j.1651-2227.1993.tb12699.x. [DOI] [PubMed] [Google Scholar]
  22. Henter J. I., Elinder G., Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991 Feb;18(1):29–33. [PubMed] [Google Scholar]
  23. Henter J. I., Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr. 1997 Mar;130(3):358–365. doi: 10.1016/s0022-3476(97)70196-3. [DOI] [PubMed] [Google Scholar]
  24. Imashuku S., Hibi S., Fujiwara F., Ikushima S., Todo S. Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Br J Haematol. 1994 Nov;88(3):656–658. doi: 10.1111/j.1365-2141.1994.tb05095.x. [DOI] [PubMed] [Google Scholar]
  25. Imashuku S., Hibi S., Ohara T., Iwai A., Sako M., Kato M., Arakawa H., Sotomatsu M., Kataoka S., Asami K. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood. 1999 Mar 15;93(6):1869–1874. [PubMed] [Google Scholar]
  26. Imashuku S., Hibi S., Ohara T., Iwai A., Sako M., Kato M., Arakawa H., Sotomatsu M., Kataoka S., Asami K. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood. 1999 Mar 15;93(6):1869–1874. [PubMed] [Google Scholar]
  27. Ishii E., Ohga S., Aoki T., Yamada S., Sako M., Tasaka H., Kuwano A., Sasaki M., Tsunematsu Y., Ueda K. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol. 1991;85(2):93–99. doi: 10.1159/000204864. [DOI] [PubMed] [Google Scholar]
  28. Janka G. E. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983 Jun-Jul;140(3):221–230. doi: 10.1007/BF00443367. [DOI] [PubMed] [Google Scholar]
  29. Janka G., Imashuku S., Elinder G., Schneider M., Henter J. I. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998 Apr;12(2):435–444. doi: 10.1016/s0889-8588(05)70521-9. [DOI] [PubMed] [Google Scholar]
  30. Kadin M. E., Kamoun M., Lamberg J. Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis. N Engl J Med. 1981 Mar 12;304(11):648–653. doi: 10.1056/NEJM198103123041106. [DOI] [PubMed] [Google Scholar]
  31. Kaito K., Kobayashi M., Katayama T., Otsubo H., Ogasawara Y., Sekita T., Saeki A., Sakamoto M., Nishiwaki K., Masuoka H. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol. 1997 Oct;59(4):247–253. doi: 10.1111/j.1600-0609.1997.tb00984.x. [DOI] [PubMed] [Google Scholar]
  32. Kawaguchi H., Miyashita T., Herbst H., Niedobitek G., Asada M., Tsuchida M., Hanada R., Kinoshita A., Sakurai M., Kobayashi N. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest. 1993 Sep;92(3):1444–1450. doi: 10.1172/JCI116721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Keréveur A., McIlroy D., Samri A., Oksenhendler E., Clauvel J. P., Autran B. Up-regulation of adhesion and MHC molecules on splenic monocyte/macrophages in adult haemophagocytic syndrome. Br J Haematol. 1999 Mar;104(4):871–877. doi: 10.1046/j.1365-2141.1999.01247.x. [DOI] [PubMed] [Google Scholar]
  34. Kitabayashi A., Hirokawa M., Kuroki J., Nishinari T., Niitsu H., Miura A. B. Successful vidarabine therapy for adenovirus type 11-associated acute hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994 Nov;14(5):853–854. [PubMed] [Google Scholar]
  35. Koch W. C., Massey G., Russell C. E., Adler S. P. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr. 1990 Mar;116(3):355–359. doi: 10.1016/s0022-3476(05)82820-3. [DOI] [PubMed] [Google Scholar]
  36. Koduri P. R., Carandang G., DeMarais P., Patel A. R. Hyperferritinemia in reactive hemophagocytic syndrome report of four adult cases. Am J Hematol. 1995 Jul;49(3):247–249. doi: 10.1002/ajh.2830490314. [DOI] [PubMed] [Google Scholar]
  37. Komp D. M., McNamara J., Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood. 1989 Jun;73(8):2128–2132. [PubMed] [Google Scholar]
  38. Kumakura S., Ishikura H., Munemasa S., Adachi T., Murakawa Y., Kobayashi S. Adult onset Still's disease associated hemophagocytosis. J Rheumatol. 1997 Aug;24(8):1645–1648. [PubMed] [Google Scholar]
  39. Lay J. D., Tsao C. J., Chen J. Y., Kadin M. E., Su I. J. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997 Oct 15;100(8):1969–1979. doi: 10.1172/JCI119728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Löw P., Neipel F., Rascu A., Steininger H., Manger B., Fleckenstein B., Kalden J. R., Harrer T. Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome. Eur J Med Res. 1998 Oct 14;3(10):461–464. [PubMed] [Google Scholar]
  41. Martin J. J., Cras P. Familial erythrophagocytic lymphohistiocytosis. A neuropathologic study. Acta Neuropathol. 1985;66(2):140–144. doi: 10.1007/BF00688689. [DOI] [PubMed] [Google Scholar]
  42. Matzner Y., Behar A., Beeri E., Gunders A. E., Hershko C. Systemic leishmaniasis mimicking malignant histiocytosis. Cancer. 1979 Jan;43(1):398–402. doi: 10.1002/1097-0142(197901)43:1<398::aid-cncr2820430156>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  43. Mori M., Kurozumi H., Akagi K., Tanaka Y., Imai S., Osato T. Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis. N Engl J Med. 1992 Jul 2;327(1):58–58. doi: 10.1056/NEJM199207023270118. [DOI] [PubMed] [Google Scholar]
  44. Morris J. A., Adamson A. R., Holt P. J., Davson J. Still's disease and the virus-associated haemophagocytic syndrome. Ann Rheum Dis. 1985 May;44(5):349–353. doi: 10.1136/ard.44.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Mroczek E. C., Weisenburger D. D., Grierson H. L., Markin R., Purtilo D. T. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med. 1987 Jun;111(6):530–535. [PubMed] [Google Scholar]
  46. Ohadi M., Lalloz M. R., Sham P., Zhao J., Dearlove A. M., Shiach C., Kinsey S., Rhodes M., Layton D. M. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet. 1999 Jan;64(1):165–171. doi: 10.1086/302187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ohga S., Matsuzaki A., Nishizaki M., Nagashima T., Kai T., Suda M., Ueda K. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol. 1993 Aug;15(3):291–298. [PubMed] [Google Scholar]
  48. Ohshima K., Suzumiya J., Sugihara M., Nagafuchi S., Ohga S., Kikuchi M. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome. Pathol Int. 1998 Dec;48(12):934–943. doi: 10.1111/j.1440-1827.1998.tb03864.x. [DOI] [PubMed] [Google Scholar]
  49. Onishi R., Namiuchi S. Hemophagocytic syndrome in a patient with rheumatoid arthritis. Intern Med. 1994 Oct;33(10):607–611. doi: 10.2169/internalmedicine.33.607. [DOI] [PubMed] [Google Scholar]
  50. Ost A., Nilsson-Ardnor S., Henter J. I. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology. 1998 Apr;32(4):310–316. doi: 10.1046/j.1365-2559.1998.00377.x. [DOI] [PubMed] [Google Scholar]
  51. Osugi Y., Hara J., Tagawa S., Takai K., Hosoi G., Matsuda Y., Ohta H., Fujisaki H., Kobayashi M., Sakata N. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997 Jun 1;89(11):4100–4103. [PubMed] [Google Scholar]
  52. Oyama Y., Amano T., Hirakawa S., Hironaka K., Suzuki S., Ota Z. Haemophagocytic syndrome treated with cyclosporin A: a T cell disorder? Br J Haematol. 1989 Oct;73(2):276–278. doi: 10.1111/j.1365-2141.1989.tb00269.x. [DOI] [PubMed] [Google Scholar]
  53. Purtilo D. T., DeFlorio D., Jr, Hutt L. M., Bhawan J., Yang J. P., Otto R., Edwards W. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N Engl J Med. 1977 Nov 17;297(20):1077–1080. doi: 10.1056/NEJM197711172972001. [DOI] [PubMed] [Google Scholar]
  54. Reiner A. P., Spivak J. L. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 1988 Nov;67(6):369–388. [PubMed] [Google Scholar]
  55. Risdall R. J., McKenna R. W., Nesbit M. E., Krivit W., Balfour H. H., Jr, Simmons R. L., Brunning R. D. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979 Sep;44(3):993–1002. doi: 10.1002/1097-0142(197909)44:3<993::aid-cncr2820440329>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  56. Rubin C. M., Burke B. A., McKenna R. W., McClain K. L., White J. G., Nesbit M. E., Jr, Filipovich A. H. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer. 1985 Aug 1;56(3):524–530. doi: 10.1002/1097-0142(19850801)56:3<524::aid-cncr2820560320>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  57. Sailler L., Duchayne E., Marchou B., Brousset P., Pris J., Massip P., Corberand J., Arlet P. Aspects étiologiques des hémophagocytoses réactionnelles: étude rétrospective chez 99 patients. Rev Med Interne. 1997;18(11):855–864. doi: 10.1016/s0248-8663(97)81959-5. [DOI] [PubMed] [Google Scholar]
  58. Smith K. J., Skelton H. G., Yeager J., Angritt P., Wagner K., James W. D., Giblin W. J., Lupton G. P. Cutaneous histopathologic, immunohistochemical, and clinical manifestations in patients with hemophagocytic syndrome. Military Medical Consortium for Applied Retroviral Research (MMCARR). Arch Dermatol. 1992 Feb;128(2):193–200. [PubMed] [Google Scholar]
  59. Stéphan J. L., Donadieu J., Ledeist F., Blanche S., Griscelli C., Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood. 1993 Oct 15;82(8):2319–2323. [PubMed] [Google Scholar]
  60. Su I. J., Chen R. L., Lin D. T., Lin K. S., Chen C. C. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol. 1994 Jun;144(6):1219–1225. [PMC free article] [PubMed] [Google Scholar]
  61. Su I. J., Hsu Y. H., Lin M. T., Cheng A. L., Wang C. H., Weiss L. M. Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer. 1993 Sep 15;72(6):2019–2027. doi: 10.1002/1097-0142(19930915)72:6<2019::aid-cncr2820720638>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  62. Takada H., Ohga S., Mizuno Y., Suminoe A., Matsuzaki A., Ihara K., Kinukawa N., Ohshima K., Kohno K., Kurimoto M. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol. 1999 Jul;106(1):182–189. doi: 10.1046/j.1365-2141.1999.01504.x. [DOI] [PubMed] [Google Scholar]
  63. Toyoshige M., Takahashi H. Increase of platelet-associated IgG (PA-IgG) and hemophagocytosis of neutrophils and platelets in parvovirus B19 infection. Int J Hematol. 1998 Feb;67(2):205–206. doi: 10.1016/s0925-5710(98)00008-5. [DOI] [PubMed] [Google Scholar]
  64. Tsuda H., Fujisao S. Th1/Th2 milieu in adult hemophagocytic syndrome. Acta Haematol. 1999;101(3):157–160. doi: 10.1159/000040944. [DOI] [PubMed] [Google Scholar]
  65. Tsuda H., Shirono K. Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor. Br J Haematol. 1996 Jun;93(3):572–575. doi: 10.1046/j.1365-2141.1996.d01-1707.x. [DOI] [PubMed] [Google Scholar]
  66. Watanabe M., Shimamoto Y., Yamaguchi M., Inada S., Miyazaki S., Sato H. Viral-associated haemophagocytosis and elevated serum TNF-alpha with parvovirus-B19-related pancytopenia in patients with hereditary spherocytosis. Clin Lab Haematol. 1994 Jun;16(2):179–182. doi: 10.1111/j.1365-2257.1994.tb00404.x. [DOI] [PubMed] [Google Scholar]
  67. Wong K. F., Chan J. K., Lo E. S., Wong C. S. A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Hum Pathol. 1996 Nov;27(11):1239–1242. doi: 10.1016/s0046-8177(96)90321-4. [DOI] [PubMed] [Google Scholar]
  68. Wong K. F., Chan J. K. Reactive hemophagocytic syndrome--a clinicopathologic study of 40 patients in an Oriental population. Am J Med. 1992 Aug;93(2):177–180. doi: 10.1016/0002-9343(92)90048-g. [DOI] [PubMed] [Google Scholar]
  69. Wong K. F., Hui P. K., Chan J. K., Chan Y. W., Ha S. Y. The acute lupus hemophagocytic syndrome. Ann Intern Med. 1991 Mar 1;114(5):387–390. doi: 10.7326/0003-4819-114-5-387. [DOI] [PubMed] [Google Scholar]
  70. Yang C. W., Pan M. J., Wu M. S., Chen Y. M., Tsen Y. T., Lin C. L., Wu C. H., Huang C. C. Leptospirosis: an ignored cause of acute renal failure in Taiwan. Am J Kidney Dis. 1997 Dec;30(6):840–845. doi: 10.1016/s0272-6386(97)90091-3. [DOI] [PubMed] [Google Scholar]
  71. Yao M., Cheng A. L., Su I. J., Lin M. T., Uen W. C., Tien H. F., Wang C. H., Chen Y. C. Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Br J Haematol. 1994 Jul;87(3):535–543. doi: 10.1111/j.1365-2141.1994.tb08309.x. [DOI] [PubMed] [Google Scholar]
  72. Yasuda S., Tsutsumi A., Nakabayashi T., Horita T., Ichikawa K., Ieko M., Koike T. Haemophagocytic syndrome in a patient with dermatomyositis. Br J Rheumatol. 1998 Dec;37(12):1357–1358. doi: 10.1093/rheumatology/37.12.1357. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES